Want to see JP:4564 full AI Analyst Report?

OncoTherapy Science (4564) Cash flow

2 Followers

OncoTherapy Science Cash Flow

JP:4564's free cash flow for Q4 2024 was ¥0.00. For the 2024 fiscal year, JP:4564's free cash flow was decreased by ¥-169.67M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.

Cash Flow	Mar 26	Mar 25	Mar 24	Mar 22	Mar 21
Operating Cash Flow	¥ -922.75M	¥ -815.02M	¥ -1.23B	¥ -794.90M	¥ -1.76B
Investing Cash Flow	¥ -63.22M	¥ -279.00K	¥ -33.35M	¥ -20.32M	¥ -52.23M
Financing Cash Flow	¥ 2.24B	¥ 1.12B	¥ 671.37M	¥ 95.95M	¥ 0.00
End Cash Position	¥ 2.09B	¥ 833.88M	¥ 527.66M	¥ 1.12B	¥ 2.90B
Free Cash Flow	¥ -984.97M	¥ -815.30M	¥ -1.23B	¥ -800.29M	¥ -1.81B

Currency in JPY